Literature DB >> 31627713

miR-34b/c regulates doxorubicin-induced myocardial cell injury through ITCH.

Wen-Cai Zhang1, Jin-Hua Yang1, Guang-Hui Liu1, Fan Yang1, Jun-Long Gong1, Meng-Ge Jia1, Meng-Juan Zhang1, Luo-Sha Zhao1.   

Abstract

Objective: To determine the underlying mechanism of miR-34b/c in regulating doxorubicin (Dox)-induced myocardial cell injury.
Methods: The viability of mouse myocardial cells HL-1 was detected by MTT assay. The apoptosis of HL-1 cells was detected by TUNEL assay. mRNA expressions of ITCH, TNF-α and IL-6 were measured by qRT-PCR. Protein levels of ITCH, NF-κB, TNF-α and IL-6 were measured by western blot. Dual luciferase assay was performed to detect the regulation of miR-34b/c on ITCH. Mouse model of cardiomyopathy was induced by intraperitoneal injection of Dox.
Results: Dox reduced HL-1 cell viability and activated NF-κB pathway in HL-1 cells. miR-34b/c expressions were gradually up-regulated and ITCH expression was gradually down-regulated in Dox-treated HL-1 cells. miR-34b/c expression had negative correlation with the mRNA expression of ITCH. Besides, ITCH was a target of miR-34b/c. miR-34b/c mimic reduced cell viability, suppressed ITCH expression, increased TNF-α and IL-6 level, and promoted NF-κB expression in nucleus and cytoplasm of HL-1 cells. Whereas silencing miR-34 protected HL-1 cells through regulating ITCH. Finally, we demonstrated miR-34 antagomir-protected myocardial cells in mouse model of cardiomyopathy.
Conclusion: miR-34b/c decreased HL-1 cell viability and promoted the secretion of proinflammatory cytokines in Dox-induced myocardial cells through ITCH/NF-κB pathway.

Entities:  

Keywords:  Doxorubicin; ITCH; NF-κB; miR-34b/c; myocardial cell

Year:  2019        PMID: 31627713      PMCID: PMC6927715          DOI: 10.1080/15384101.2019.1673618

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  39 in total

1.  HECT-type ubiquitin ligase ITCH targets lysosomal-associated protein multispanning transmembrane 5 (LAPTM5) and prevents LAPTM5-mediated cell death.

Authors:  Takaya Ishihara; Jun Inoue; Ken-Ichi Kozaki; Issei Imoto; Johji Inazawa
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

Review 2.  Multiple facets of NF-κB in the heart: to be or not to NF-κB.

Authors:  Joseph W Gordon; James A Shaw; Lorrie A Kirshenbaum
Journal:  Circ Res       Date:  2011-04-29       Impact factor: 17.367

3.  ASPP2 suppresses invasion and TGF-β1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.

Authors:  Yasuyuki Gen; Kohichiroh Yasui; Tomoko Kitaichi; Naoto Iwai; Kei Terasaki; Osamu Dohi; Hikaru Hashimoto; Hayato Fukui; Yutaka Inada; Akifumi Fukui; Masayasu Jo; Michihisa Moriguchi; Taichiro Nishikawa; Atushi Umemura; Kanji Yamaguchi; Hiroyuki Konishi; Yuji Naito; Yoshito Itoh
Journal:  Cancer Lett       Date:  2017-04-09       Impact factor: 8.679

4.  Upregulated microRNA-214 enhances cardiac injury by targeting ITCH during coxsackievirus infection.

Authors:  Zhi-Gang Chen; Hui Liu; Jun-Biao Zhang; Shao-Li Zhang; Li-Hua Zhao; Wan-Qian Liang
Journal:  Mol Med Rep       Date:  2015-03-24       Impact factor: 2.952

5.  VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.

Authors:  Markus Räsänen; Joni Degerman; Tuuli A Nissinen; Ilkka Miinalainen; Risto Kerkelä; Antti Siltanen; Janne T Backman; Eero Mervaala; Juha J Hulmi; Riikka Kivelä; Kari Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

6.  Sulforaphane protects the heart from doxorubicin-induced toxicity.

Authors:  Preeti Singh; Rajendra Sharma; Kevin McElhanon; Charles D Allen; Judit K Megyesi; Helen Beneš; Sharda P Singh
Journal:  Free Radic Biol Med       Date:  2015-05-27       Impact factor: 7.376

7.  Silencing of circRNA.2837 Plays a Protective Role in Sciatic Nerve Injury by Sponging the miR-34 Family via Regulating Neuronal Autophagy.

Authors:  Zhi-Bin Zhou; Yu-Long Niu; Gao-Xiang Huang; Jia-Jia Lu; Aimin Chen; Lei Zhu
Journal:  Mol Ther Nucleic Acids       Date:  2018-07-25       Impact factor: 8.886

8.  Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.

Authors:  Paola Bonetti; Montserrat Climent; Fabiana Panebianco; Chiara Tordonato; Angela Santoro; Matteo Jacopo Marzi; Pier Giuseppe Pelicci; Andrea Ventura; Francesco Nicassio
Journal:  Oncogene       Date:  2018-08-09       Impact factor: 9.867

9.  MicroRNA-195 Regulates Metabolism in Failing Myocardium Via Alterations in Sirtuin 3 Expression and Mitochondrial Protein Acetylation.

Authors:  Xiaokan Zhang; Ruiping Ji; Xianghai Liao; Estibaliz Castillero; Peter J Kennel; Danielle L Brunjes; Marcus Franz; Sven Möbius-Winkler; Konstantinos Drosatos; Isaac George; Emily I Chen; Paolo C Colombo; P Christian Schulze
Journal:  Circulation       Date:  2018-01-12       Impact factor: 29.690

Review 10.  Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity.

Authors:  Shreesh Ojha; Hasan Al Taee; Sameer Goyal; Umesh B Mahajan; Chandrgouda R Patil; D S Arya; Mohanraj Rajesh
Journal:  Oxid Med Cell Longev       Date:  2016-05-23       Impact factor: 6.543

View more
  3 in total

Review 1.  Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments.

Authors:  Wanli Sun; Juping Xu; Li Wang; Yuchen Jiang; Jingrun Cui; Xin Su; Fan Yang; Li Tian; Zeyu Si; Yanwei Xing
Journal:  Front Cardiovasc Med       Date:  2022-08-23

Review 2.  MicroRNAs in Cancer Treatment-Induced Cardiotoxicity.

Authors:  Laura Pellegrini; Sara Sileno; Marco D'Agostino; Eleonora Foglio; Maria Cristina Florio; Vincenzo Guzzanti; Matteo Antonio Russo; Federica Limana; Alessandra Magenta
Journal:  Cancers (Basel)       Date:  2020-03-17       Impact factor: 6.639

Review 3.  Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity.

Authors:  Xinyu Yang; Guoping Li; Tao Yang; Manke Guan; Na An; Fan Yang; Qianqian Dai; Changming Zhong; Changyong Luo; Yonghong Gao; Saumya Das; Yanwei Xing; Hongcai Shang
Journal:  Oxid Med Cell Longev       Date:  2020-10-13       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.